ARCHIVES

CCOPS Unhappy With NCI Policy Limiting Their Participation In Early Phase 2 Clinical Trials

This article is from The Cancer Letter archive.

Vol. 09 No. 43 | November 11, 1983

Download PDF Visit The Full Archive

Related Articles

Dana-Farber Correction Plan Sent To State; Pharmacy Chief Resigns

June 9, 1995

Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies

April 26, 2013

DCE Board Approve Concepts For Contract Recompetitions

November 23, 1984

ASCO President Swain: “Shattering Impact on Cancer Enterprise”

February 15, 2013

ICCCR Issues RFP For Cancer Risk Scale

March 6, 1992

Senate Markup Of Labor-HSS-Education Money Bill Delayed Until After Congress August Recess

August 4, 1989